Each pre-filled pen contains 150 mg risankizumab in 1 mL solution.
Risankizumab is a humanised immunoglobulin G1 (IgG1) monoclonal antibody selective to the interleukin (IL)-23 protein produced in Chinese Hamster Ovary cells using recombinant DNA technology.
Excipients/Inactive Ingredients: Sodium acetate trihydrate, Acetic acid, Trehalose dihydrate, Polysorbate 20, Water for injections.